Treatment of ophthalmic disorders using urea and urea derivatives
Details for Australian Patent Application No. 2003213084 (hide)
International Classifications
Event Publications
24 July 2003 Complete Application Filed
Priority application(s): 60/357,574 15.02.02 US; 60/357,347 13.02.02 US
2 October 2003 Application Open to Public Inspection
Published as AU-B-2003213084
26 June 2008 Application Accepted
Published as AU-B-2003213084
23 October 2008 Standard Patent Sealed
3 November 2011 Assignment Registered
Vitreo-Retinal Technologies, Inc. The patent has been assigned to Numoda Biotechnologies, Inc.
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2003213085-SYSTEMS AND METHODS FOR FAIR ARBITRATION BETWEEN MULTIPLE REQUEST SIGNALS
2003213083-CONSISTENCY MODELING OF HEALTHCARE CLAIMS TO DETECT FRAUD AND ABUSE
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
![](/images/main/3dbox_small.png)
- Editable Word format reports
- For IP Professionals
- Multiuser